New Boron Delivery Agents
Cancer Biotherapy and Radiopharmaceuticals · 2023-04 · 38 (3) · 160-172
DOI: 10.1089/cbr.2022.0060 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Biotherapy and Radiopharmaceuticals, online erschienen am 05.04.2023. Verfasst von Annette G Beck-Sickinger und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Life Sciences, Institute of Biochemistry, Leipzig University, Leipzig, Germany. Hauptthemen laut MEDLINE: Neoplasms, Boron Neutron Capture Therapy. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
This proceeding article compiles current research on the development of boron delivery drugs for boron neutron capture therapy that was presented and discussed at the National Cancer Institute (NCI) Workshop on Neutron Capture Therapy that took place on April 20–22, 2022. The most used boron sources are icosahedral boron clusters attached to peptides, proteins (such as albumin), porphyrin derivatives, dendrimers, polymers, and nanoparticles, or encapsulated into liposomes. These boron clusters and/or carriers can be labeled with contrast agents allowing for the use of imaging techniques, such as PET, SPECT, and fluorescence, that enable quantification of tumor-localized boron and their use as theranostic agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Life Sciences, Institute of Biochemistry, Leipzig University, Leipzig, Germany.
- Department of Chemistry and Biochemistry, Loyola University Chicago, Chicago, Illinois, USA.
- Department of Neurosurgery, Cedars-Sinai Medical Center, Los Angeles, California, USA.
- Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, New York, USA.
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Department of Surgery, Weill Cornell Medical College of Cornell University, New York, New York, USA.
ORCID-Profile: Maria da Graça H Vicente
Förderung
- NCI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Beck-Sickinger, A. G., Becker, D. P., Chepurna, O., Das, B., Flieger, S., Hey-Hawkins, E., Hosmane, N., Jalisatgi, S. S., Nakamura, H., Patil, R., Vicente, M. D. G. H., & Viñas, C. (2023). New Boron Delivery Agents. Cancer Biotherapy and Radiopharmaceuticals, 38(3), 160-172. https://doi.org/10.1089/cbr.2022.0060
Vancouver
Beck-Sickinger AG, Becker DP, Chepurna O, Das B, Flieger S, Hey-Hawkins E, et al. New Boron Delivery Agents. Cancer Biotherapy and Radiopharmaceuticals. 2023;38(3):160-172. doi:10.1089/cbr.2022.0060
BibTeX
@article{BeckSickinger2023,
author = {Beck-Sickinger, Annette G and Becker, Daniel P and Chepurna, Oksana and Das, Bhaskar and Flieger, Sebastian and Hey-Hawkins, Evamarie and Hosmane, Narayan and Jalisatgi, Satish S and Nakamura, Hiroyuki and Patil, Rameshwar and Vicente, Maria da Graça H and Viñas, Clara},
title = {New Boron Delivery Agents},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
year = {2023},
volume = {38},
number = {3},
pages = {160--172},
doi = {10.1089/cbr.2022.0060}
}
EUVIMED